Measuring heart calcium levels in adults treated for childhood cancer
Official title: Study of Coronary Calcium Score as a Marker of Post-radiation Vascular Dysplasia in Adults Treated During Childhood for Cancer With Mediastinal Irradiation
Run by Gustave Roussy, Cancer Campus, Grand Paris · NCT03604627 · Data updated 2026-11-12
This study is testing if adults who had radiation therapy for childhood cancer have higher heart calcium levels compared to others, to see if the treatment affects their heart health.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Gustave Roussy, Cancer Campus, Grand Paris Academic / other |
| Drugs / interventions | doxorubicin |
| Locations | 3 sites (Villejuif, Val De Marne and 2 other locations) |
| Status | Recruiting |
| Started | June 14, 2018 |
| Main results expected | September 2028 |
| Study ends | September 2028 |
| Registry record updated | May 29, 2024 |
| Trial ID | NCT03604627 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who were treated for cancer during childhood with heart irradiation or anthracycline therapy and have been in remission for at least 10 years.
✕Probably not a fit
Patients who have not been in remission for at least 10 years or those who have not received heart irradiation or anthracycline treatment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the coronary calcium score in adults who received radiation therapy to the heart area during childhood or adolescence for cancer treatment. It will compare the calcium scores of these individuals to assess whether radiation exposure is linked to increased calcium levels, while adjusting for other cardiovascular risk factors such as age, sex, and pre-existing conditions. The study focuses on patients who have been in complete remission for at least 10 years and are now adults. The primary intervention involves measuring the coronary calcium score using imaging techniques.
Why it matters
Potential benefit: If successful, this study could help identify cardiovascular risks in survivors of childhood cancer, leading to better monitoring and preventive strategies.
How similar studies have gone: Other studies have indicated potential links between radiation therapy and cardiovascular issues, suggesting that this approach may yield valuable insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients 18 years of age or older, 2. Treated for cancer during childhood, adolescence or young adulthood (≤25 years), 3. Treated with irradiation of the heart area (≥20% of ≥5Gy heart rate) and / or anthracycline (cumulative dose of doxorubicin equivalent ≥300mg/m\^²), 4. In complete remission of their pediatric cancer for at least 10 years, 5. Patient affiliated to a social security scheme or beneficiary of such a scheme, 6. Patient Information and Signed Informed Consent. Exclusion Criteria: 1. Perspective less than 10 years, 2. Persons deprived of liberty or guardianship (including trusteeship), 3. Impossibility of submitting to the medical follow-up of the test for geographical, social or psychological reasons, 4. Pregnant women. Inclusion criteria for extension cohort: 1. Patients 30 years of age or older, 2. Treated for cancer during childhood, adolescence or young adulthood (≤25 years), 3. Treated with irradiation of the heart area (≥20% of ≥5Gy heart rate), 4. In complete remission of their pediatric cancer for at least 10 years, 5. Patient affiliated to a social security scheme or beneficiary of such a scheme, 6. Patient Information and Signed Informed Consent. Exclusion criteria for extension cohort: 1. Persons deprived of liberty or guardianship (including trusteeship), 2. Impossibility of submitting to the medical follow-up of the test for geographical, social or psychological reasons, 3. Pregnant women.
Where it's running
-
Gustave Roussy
Villejuif, Val De Marne, France Recruiting -
Hôpital Bichat
Paris, France Recruiting -
Hôpital Trousseau
Paris, France Recruiting
Study contacts
- Study coordinator: Brice FRESNEAU, MD
- Email: brice.fresneau@gustaveroussy.fr
- Phone: +33 (0)1 42 11 42 11
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Community-led, family-centered communication for Hispanic childhood cancer survivors
This study tests a family-focused communication approach to help young Hispanic adult survivors, their families, and clinicians talk more effectively about survivorship care.
-
Blood biomarkers for treatment-related brain injury in children with brain tumors
This project will test whether blood plasma biomarkers can show treatment-related brain injury in children with primary brain tumors by comparing those who receive radiotherapy, those who do not, and healthy children of the same age and sex.
-
At-home light therapy for chemo-related nerve pain in childhood cancer survivors
This study tests whether a six-week at-home light therapy program can help childhood cancer survivors who have chemotherapy-induced peripheral neuropathy.
-
Understanding the needs of siblings of children with cancer
This study looks at the emotional struggles of siblings of kids with cancer to see how they feel and what support they need during this tough time.
-
Cognitively engaging exercise to boost thinking skills in children and teens with cancer
This trial tests whether mentally challenging physical activity can improve thinking skills and self-control (executive functions) in children and adolescents undergoing cancer treatment.
-
Examining muscle function in survivors of childhood leukemia
This study is trying to see how cancer treatment affects muscle strength and function in survivors of childhood leukemia compared to healthy kids.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.